Axel Merseburger is Professor of Urology and Chairman of the Department of Urology at University Hospital Schleswig‑Holstein, Campus Lübeck, Lübeck, Germany. He studied medicine at Hannover Medical School, Hannover, Germany, before completing a residency in surgery and urology at the Eberhard Karls University, Tübingen, Germany, and a research fellowship at the Miller School of Medicine, Miami, FL, USA. Prior to his current role, he was Associate Professor and Professor at Hannover Medical School, and Chairman of the Department of Urology at the University of Lübeck, in Lübeck. Prof. Merseburger is trained in all aspects of open and endoscopic urology and has a specific interest in laparoscopic and robotic-assisted surgery, particularly for the management of prostate, renal, and bladder cancer.
Prof. Merseburger’s research activity encompasses both molecular and clinical aspects of uro-oncology, focusing on biomarkers and prognostic factors for prostate cancer, renal cell carcinoma, and transitional cell carcinoma. He is Principal Investigator in multiple phase 2 and 3 uro-oncology clinical trials. Prof. Merseburger is a member of various uro-oncology organisations, is Chair-elect for the European Scholarship Programme (ESUP) of the European Association of Urology (EAU), and was the Chairman of the EAU Guideline Group for Lasers and Technologies.
Prof. Merseburger is a reviewer and editorial board member for several urology and oncology journals, and serves as Associate Editor of the World Journal of Urology and Editor-in-Chief of the European Journal of Haematology and Oncology and Aktuelle Urologie. He has published widely in the field, having authored or co-authored over 300 peer-reviewed articles.
EM-80450 - Date of preparation : November 2021